Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Apr;29(4):449-56.
doi: 10.1039/c2np00066k. Epub 2012 Feb 14.

Largazole: from discovery to broad-spectrum therapy

Affiliations
Review

Largazole: from discovery to broad-spectrum therapy

Jiyong Hong et al. Nat Prod Rep. 2012 Apr.

Abstract

The cyclic depsipeptide largazole from a cyanobacterium of the genus Symploca is a marine natural product with a novel chemical scaffold and potently inhibits class I histone deacetylases (HDACs). Largazole possesses highly differential growth-inhibitory activity, preferentially targeting transformed over non-transformed cells. The intriguing structure and biological activity of largazole have attracted strong interest from the synthetic chemistry community to establish synthetic routes to largazole and to investigate its potential as a cancer therapeutic. This Highlight surveys recent advances in this area with a focus on the discovery, synthesis, target identification, structure-activity relationships, HDAC8-largazole thiol crystal structure, and biological studies, including in vivo anticancer and osteogenic activities.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structure of largazole.
Fig. 2
Fig. 2
Chemical degradation to determine the absolute configuration of stereogenic centers. a) O3, CH2Cl2, 25 °C, 30 min; b) H2O2–HCO2H (1:2), 70 °C, 20 min; c) 6 N HCl, 110 °C, 24 h.
Fig. 3
Fig. 3
Putative mechanism of largazole action. A) Modes of action of largazole and FK228 to liberate potent HDAC inhibitors. B) Molecular docking of largazole thiol into an HDAC1 homology model. PG = Protecting group.
Fig. 4
Fig. 4
Synthetic approaches to largazole.
Fig. 5
Fig. 5
HDAC8–largazole thiol complex. The catalytic Zn2+ ion (red sphere) is coordinated by D178, H180, and D267 (blue sticks). Largazole thiol is shown as a stick figure (C = magenta, N = blue, O = red, and S = yellow). Structural K+ ions appear as green spheres. Reprinted with permission from K. E. Cole, D. P. Dowling, M. A. Boone, A. J. Phillips and D. W. Christianson, J. Am. Chem. Soc., 2011, 133, 12474–12477. Copyright 2011 American Chemical Society.
Fig. 6
Fig. 6
Structure–activity relationships of largazole.
Fig. 7
Fig. 7
In vitro and in vivo osteogenic activities of largazole. Arrows indicate the region of newly forming woven bone. Reprinted with permission from S.-U. Lee, H. B. Kwak, S.-H. Pi, H.-K. You, S. R. Byeon, Y. Ying, H. Luesch, J. Hong and S. H. Kim, ACS Med. Chem. Lett., 2011, 2, 248–251. Copyright 2011 American Chemical Society.

References

    1. Moore RE, Corbett TH, Patterson GML, Valeriote FA. Curr Pharm Des. 1996;2:317–330.
    1. Nunnery JK, Mevers E, Gerwick WH. Curr Opin Biotechnol. 2010;21:787–793. - PMC - PubMed
    1. Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH. Invest New Drugs. 2005;23:213–224. - PubMed
    1. Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH. J Nat Prod. 2001;64:907–910. - PubMed
    1. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm268781.htm

Publication types

MeSH terms